Hedge Fund News: Cliff Asness, Dan Loeb’s Third Point Reinsurance Ltd., Textron Inc. (TXT)

Page 1 of 2

Editor’s Note: Related Ticker: Textron Inc. (NYSE:TXT)

AQR CAPITAL MANAGEMENTAQR puts academic theory into practice (Risk.net)
“Those who can’t, do research,” goes the adage, a twist on George Bernard Shaw’s famous quip on the failures of academia. The partners at AQR Capital Management beg to differ. Three of the founders of the $80 billion hedge fund – Cliff Asness, John Liew and Robert Krail – toiled away in the ivory towers of academia before putting their theories into practice with phenomenal results in the trenches of Goldman Sachs’ proprietary trading division. Even now AQR sees the academic world as a hotbed for ideas that can be turned into real-world investment strategies and products.

Loeb’s Reinsurer With No U.S. Staff Gains From Jobs Act (Bloomberg)
Billionaire hedge-fund manager Daniel Loeb’s Third Point Reinsurance Ltd., which has no staff in the U.S., said it can limit financial disclosure after a public offering because of rules promoting domestic job creation. Third Point Re is an “emerging growth company” under the Jumpstart Our Business Startups — or JOBS — Act, according to filings for the planned initial public offering. Under the act, companies with less than $1 billion in annual revenue can qualify, allowing reduced disclosure about executive pay and waiving requirements for auditors to attest to a company’s financial controls.

HFRI: Hedge Funds Rise 1.36% To Open Second Half (FINalternatives)
Hedge funds enjoyed broadly positive returns in July, according to a report from Hedge Fund Research. The HFRI Fund Weighted Composite Index rose 1.36% last month and is up 4.73% on the year. Most strategies tracked by the index suite were in the black in July. “In sharp contrast to the volatile, risk-off sentiment of the prior month, hedge fund performance in July was driven by a positive tone to earnings season and a dynamic environment for M&A including strategic transactions, shareholder activist and special situations exposures, contributing to a favorable operating environment for long/short strategies,” HFR President Kenneth Heinz said.

Textron Value in Breakup Seen Tempting Activist Investor (Bloomberg)
Activist hedge-fund managers in search of their next prey may look to Textron Inc. (NYSE:TXT). The $7.9 billion maker of Cessna planes and Bell helicopters has a valuation that lags behind 83 percent of industrial stocks in the Standard & Poor’s 500 Index, according to data compiled by Bloomberg. Credit Suisse Group AG said Providence, Rhode Island-based Textron may become susceptible to pressure from activists wanting to break up the conglomerate. While Textron Inc. (NYSE:TXT)’s earnings are forecast by analysts to surge next year to the highest level since the financial crisis, the stock is being hampered by lackluster growth at its defense unit, which could be spun off, according to industry consultant Silverline Group.

HFC donates UD$250,000 to child abuse charities (Cayman News Service)
Hedge Funds Care (HFC) Cayman, a charity for the prevention and treatment of child abuse, has allocated a total of US$250,000 in local grants this year to seven local charites that work to raise awareness in order to prevent abuse or to support abused children in the Cayman Islands. Programmes that will benefit include those that educate the public, young parents, teachers and health workers, as well as child abuse prevention education for young children at school. Hedge Funds Care Cayman was founded in 2005 as the second international affiliate of HFC. Since then, the Cayman affiliate has distributed over US$1.8 million in 47 grants to agencies and organisations in the Caymans Islands that work to prevent and treat child abuse and neglect, Hedge Funds Care’s sole mission.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!